XNAS
ARTW
Market cap19mUSD
Oct 08, Last price
3.67USD
1D
11.55%
1Q
46.51%
Jan 2017
7.94%
Name
Art's Way Manufacturing Co Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Art's-Way Manufacturing Co., Inc. manufactures and sells agricultural equipment, and specialized modular science and agricultural buildings in the United States and internationally. It operates through two segments, Agricultural Products and Modular Buildings. The Agricultural Products segment offers various specialized farm machinery, including portable and stationary animal feed processing equipment and related attachments; forage equipment, such as forage boxes, bale processors, running gears, and dump boxes; manure spreaders; sugar beet harvesting equipment; dirt work equipment; and after-market service parts. Its Modular Buildings segment produces, sells, and leases swine buildings, complex containment research laboratories, and research facilities for academic research institutions, government research and diagnostic centers, public health institutions, and private research and pharmaceutical companies. This segment also designs, manufactures, delivers, installs, and rents building units. It markets and sells its products through independent farm equipment dealers, and OEM sales channels. Art's-Way Manufacturing Co., Inc. was founded in 1956 and is headquartered in Armstrong, Iowa.
Key people
Carrie L. Gunnerson
President, Chief Executive Officer, Interim Chief Financial Officer · since 2018
Marc H. McConnell
Vice Chairman of the Board · since 2008
J. Ward Ward McConnell
Vice Chairman - Elect · since 2015
Thomas E. Buffamante
Independent Director · since 2003
David R. Castle
Independent Director · since 2000
Joseph R. Dancy
Independent Director
Legal address
C/O COGENCY GLOBAL INC.
850 NEW BURTON ROAD SUITE 201
DOVER, DE 19904
US
850 NEW BURTON ROAD SUITE 201
DOVER, DE 19904
US
Headquarters
5556 Highway 9 West Box 288
Armstrong, IA 50514
US
Armstrong, IA 50514
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑11 | 2024‑11 | 2023‑11 | 2022‑11 | 2021‑11 | 2020‑11 | 2019‑11 | 2018‑11 | 2017‑11 | 2016‑11 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||